Devonian Health Valuation
| GSD Stock | CAD 0.25 0.01 4.17% |
Devonian Health seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Devonian Health Group from reviewing the firm fundamentals such as Shares Outstanding of 148.22 M, current valuation of 26.87 M, and Profit Margin of (0.04) % as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 2.5562 | Enterprise Value 26.9 M | Enterprise Value Ebitda 191.606 | Price Sales 1.6547 | Enterprise Value Revenue 1.2 |
Overvalued
Today
Please note that Devonian Health's price fluctuation is out of control at this time. Calculation of the real value of Devonian Health Group is based on 3 months time horizon. Increasing Devonian Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Devonian stock is determined by what a typical buyer is willing to pay for full or partial control of Devonian Health Group. Since Devonian Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Devonian Stock. However, Devonian Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.25 | Real 0.19 | Hype 0.28 | Naive 0.25 |
The intrinsic value of Devonian Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Devonian Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Devonian Health Group helps investors to forecast how Devonian stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Devonian Health more accurately as focusing exclusively on Devonian Health's fundamentals will not take into account other important factors: Devonian Health Cash |
|
Devonian Health Total Value Analysis
Devonian Health Group is currently estimated to have takeover price of 26.87 M with market capitalization of 37.06 M, debt of 2.08 M, and cash on hands of 413.87 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Devonian Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
26.87 M | 37.06 M | 2.08 M | 413.87 K |
Devonian Health Investor Information
About 14.0% of the company shares are held by company insiders. The book value of Devonian Health was currently reported as 0.1. The company recorded a loss per share of 0.01. Devonian Health Group last dividend was issued on the 19th of May 2017. The entity had 1:2 split on the 19th of May 2017. Devonian Health Group is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Devonian Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Devonian Health has an asset utilization ratio of 57.97 percent. This indicates that the Company is making C$0.58 for each dollar of assets. An increasing asset utilization means that Devonian Health Group is more efficient with each dollar of assets it utilizes for everyday operations.Devonian Health Ownership Allocation
Devonian Health holds a total of 148.22 Million outstanding shares. Devonian Health Group shows 14.2 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Devonian Health Profitability Analysis
The company reported the revenue of 17.82 M. Net Loss for the year was (1.22 M) with profit before overhead, payroll, taxes, and interest of 7.18 M.About Devonian Health Valuation
Our relative valuation model uses a comparative analysis of Devonian Health. We calculate exposure to Devonian Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Devonian Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6.9 M | 7.2 M |
Additional Tools for Devonian Stock Analysis
When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.